Atom | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Funder: National Institutes of Health

Funding Amounts: Up to $500,000 total cost/year (Phase I, up to 2 years) | Up to $1,500,000 total cost/year (Phase II, up to 3 years); max 5 years total

Summary: Supports U.S. small businesses in advancing small molecule drug discovery and development for nervous system disorders, from hit optimization through IND-enabling studies and phase I clinical testing, with NIH collaboration and IP retention.

Key Information: Applicants must be U.S. small businesses; projects can enter at either discovery or development stage; clinical trial optional (up to phase I only).

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Sign in to see full grant listing